Tag: EMPROTECT
Microparticle-based MMAe effect size “consistent with other trials” despite failure to...
Middle meningeal artery embolisation (MMAe) involving microparticles—as opposed to liquid embolic agents, glues or coils—did not lead to a statistically significant reduction in six-month...
